Impact of nebulized Tranexamic Acid in control of hemoptysis
Phase 3
Recruiting
- Conditions
- Hemoptysis.Hemoptysis
- Registration Number
- IRCT20170313033051N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Moderate and severe hemoptysis
Age above 15 years old
Exclusion Criteria
History of allergy to Tranexamic Acid
Active thromboembolic event
lack of consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Volume of hemoptysis. Timepoint: first 48 h after admission. Method of measurement: Frequency and volume of hemoptysis (scaled container).
- Secondary Outcome Measures
Name Time Method eed to invasive interventions and hospital length of stay. Timepoint: first 48 h after admission. Method of measurement: Questionnaire and hospital documents.